Araki, Hidemori <br/><br/>
Relationship of pathologic factors to efficacy of sorafenib treatment in patients with metastatic clear cell renal cell carcinoma.  [electronic resource] 

 -  American journal of clinical pathology  Apr 2015 
 - 492-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1943-7722 
<br/><br/><label>Standard No.: </label>10.1309/AJCPM8RJ2ECAWOGQ  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Renal Cell--drug therapy<br/>Disease Progression<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Necrosis<br/>Neoplasm Grading<br/>Neoplasm Staging<br/>Nephrectomy<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds--therapeutic use<br/>Predictive Value of Tests<br/>Prognosis<br/>Sorafenib